未登录.png)
分享.png)
收藏分享 收藏 Immunogenicity and safety of a booster dose of the COVID-19 DNA vaccine in healthy adults aged 18 years and above: a single-center, randomized, observer-blind, placebo-controlled phase 2 trialCOVID-19 DNA疫苗加强针在18岁及以上健康成人中的免疫原性和安全性：一项单中心、随机、观察者盲法、安慰剂对照的II期试验
Yao, Aihua; Jia, Siyue; Cheng, Xin; Pan, Hongxing; Wang, Zhijian; Yang, Haitao; Xia, Yu; Xu, Jianfang; Huai, Xuefen; Leng, Danjing; Xu, Ming; Wang, Jiarong; Zhao, Gan; Wang, Bin; Li, Jingxin 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase III clinical trial in China水痘减毒活疫苗在13至55岁健康受试者中的免疫原性和安全性: 中国的双盲，随机，主动对照III期临床试验Zhang, Yang; Wang, Shiyuan; Li, Guifan; Shi, Jinhui; Chang, Xianyun; Zhang, Hao; Zhu, Fengcai; Li, Jingxin; Pan, Hongxing; Sun, Jinfang 分享 收藏 Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trialCOVID-19 DNA疫苗在健康成人和老年人中的免疫原性和安全性: 一项随机，观察者盲，安慰剂对照的2期试验Jia, Siyue; Shao, Chengwei; Cheng, Xin; Pan, Hongxing; Wang, Zhijian; Xia, Yu; Xu, Jianfang; Huai, Xuefen; Leng, Danjing; Wang, Jiarong; Zhao, Gan; Wang, Bin; Li, Jingxin; Zhu, Fengcai 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Significant impact of carbon source on microstructure and water-oxygen corrosion behavior of Si-Y alloy modified SiC/SiC compositeLi, Jingxin; Liu, Yongsheng; Chen, Pinxiao; Liu, Qiaomu; Cao, Yejie; Chen, Yulong; Li, Yunzhen; Ren, Jie; Dong, Ning; Wang, Jing 分享 收藏 Immune responses and transcription landscape of adults with the third dose of homologous and heterologous booster vaccines of COVID-19Zheng, Hui; Li, Cuidan; Zheng, Xiuyu; Jiang, Hu-Dachuan; Li, Yuqing; Yao, Aihua; Li, Xiaolong; Wang, Feiyu; Liu, Wenqing; Cao, Xiang; Qi, Runjie; Chen, Li; Jin, Lairun; Zhu, Fengcai; Li, Jingxin; Chen, Fei 分享 收藏 Unraveling the global burden of inflammatory bowel disease (1990-2019): A Joinpoint regression analysis of divergent trends in 10-24 and 50-69 age cohortsWang, Xinyi; Xiu, Ruipu; Gong, Liping; Sun, Wei; Dong, Yuxin; Liu, Weitong; Liu, Xiaoxuan; Liu, Chuanyong; Li, Jingxin; Wang, Yanqing 分享 收藏 Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control studyJia, Siyue; Yin, Zundong; Pan, Hongxing; Wang, Fuzhen; Liu, Xiaoqiang; Wang, Qing; Zhang, Li; Tang, Jihai; Yang, Hao; Du, Jiangbo; Wang, Zhiguo; Jin, Pengfei; Peng, Zhihang; Tang, Rong; Kang, Guodong; Wang, Xuewen; Li, Simin; Wang, Weixiao; Li, Jingxin; Shen, Hongbing; Zhu, Fengcai 分享 收藏 Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studiesBalgos, Abundio; Hannawi, Suad; Chen, Wen-Li; Abuquta, Alaa; Safeldin, Linda; Hassan, Aala; Alamadi, Ahmad; Tirador, Louie; Jaen, Anjuli May; Villalobos, Ralph Elvi; Mo, Chen; Yue, Zi-Jing; Ma, Ying; Wang, Qing-Shuang; Wen, Ren-Du; Yao, Zheng; Yu, Jia-Ping; Yao, Wen-Rong; Zhang, Jian-Hui; Hong, Kun-Xue; Liu, Yong; Li, Jing-Xin 分享 收藏 Vaccination with Adenovirus Type 5 Vector-Based COVID-19 Vaccine as the Primary Series in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Clinical TrialZhu, Yawen; Tang, Rong; Li, Xiaolong; Chen, Xiaoqin; Wang, Xue; Wang, Ying; Wang, Ruijie; Zhu, Fengcai; Li, Jingxin 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
